echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Who will be the first popular type of medical consortium to test the water with the volume procurement model?

    Who will be the first popular type of medical consortium to test the water with the volume procurement model?

    • Last Update: 2021-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chongming has the largest land area, the lowest population density, and the largest agricultural population among all districts and counties in Shanghai.


    Chongming has the largest land area, the lowest population density, and the largest agricultural population among all districts and counties in Shanghai.


    On March 17, Shanghai Sunshine Pharmaceutical Purchasing Network released the "Announcement on Centralized Negotiated Procurement of Drugs from the "Xinhua-Chongming" Regional Medical Consortium (the first batch of 2021)", which carried out centralized drug procurement for 15 drugs, mainly involving heart There are three categories of vascular system drugs, systemic anti-infective drugs, and gastrointestinal and metabolic drugs.


    Table 1 "Xinhua-Chongming" regional medical consortium medicines centralized bargaining purchase product catalog

    Figure 1 The distribution of treatment categories of purchased varieties

    02.


    The industry continues to pay attention to the selection rules.


    In the comprehensive evaluation of the shortlisted products, in addition to the "DRS Third Party Evaluation System" drug star comprehensive score, considering the proportion of purchases in the previous year and the coverage of medical institutions means that the existing "Xinhua-Chongming" regional medical consortium Drugs sold by medical institutions have a certain scoring advantage when they are shortlisted to avoid the situation that they are eliminated during the comprehensive evaluation of the shortlist.


    03.


    According to the data of the HMAS medical institution market analysis system, the market size of the 15 negotiated products in the "Xinhua-Chongming" regional medical consortium will be between 5 million and 30 million in 2020, and the TOP5 variety is amlodipine aspartate.


    Table 2 The market scale of 15 varieties of hospitals in the "Xinhua-Chongming" regional medical consortium in 2020

    04.


    Regardless of the market size or the announced basis for the calculation of the agreed purchases for the first year, the calcium antagonist aspartate amlodipine tablets is the largest variety in this centralized bargaining purchase quantity.


    Figure 2 2017-2020 Shanghai medical institution market size trend of amlodipine (unit: ten thousand yuan)

    Except for amlodipine aspartate, sitagliptin phosphate tablets and cefazolin sodium pentahydrate for injection have little suspense.


    05, Losartan Potassium Hydrochlorothiazide may usher in a fierce fight

    The second purchase of Losartan Potassium Hydrochlorothiazide, is the first angiotensin II receptor (AT1) antagonist and diuretic compound preparation, suitable for combined treatment of patients with hypertension.


    Figure 3 Losartan Potassium Hydrochlorothiazide Tablets Proportion of Companies in Shanghai Medical Institution Market in 2020

    06.


    In order to solve the long-standing problems of falsely high prices and irregular circulation in my country's pharmaceutical industry, the state has played the role of the government and the market to continue to promote centralized drug procurement and mass procurement, eradicating the accumulated drawbacks of gold sales and squeezing out drugs.


    For the first time, Chongming medical institutions used the medical consortium model to carry out mass procurement, which complemented the national and provincial centralized mass procurement.






    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.